You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Advanced RCC

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Renal Cell Carcinoma Trial in Heilbronn (IVAC)

Recruiting
  • Advanced Renal Cell Carcinoma
  • IVAC
  • Heilbronn, Germany
    SLK Kliniken Heilbronn, Klinik für Innere Medizin III: Hämatolog
Nov 30, 2022

RCC, Renal Cell Carcinoma Trial in Dallas (Cabozantinib 80 MG, Cabozantinib 40Mg Tab, Nivolumab)

Not yet recruiting
  • RCC
  • Renal Cell Carcinoma
  • Cabozantinib 80 MG
  • +2 more
  • Dallas, Texas
    UT Southwestern Medical Center
Jul 3, 2023

Advanced Renal Cell Carcinoma Trial in Beijing (ST-1898 tablets)

Recruiting
  • Advanced Renal Cell Carcinoma
  • ST-1898 tablets
  • Beijing, Beijing, China
    Peking University Cancer Hospital & Institute
Nov 6, 2023

Advanced Clear Cell Renal Cell Carcinoma Trial in Boston (Axitinib, Palbociclib, Avelumab)

Not yet recruiting
  • Advanced Clear Cell Renal Cell Carcinoma
  • Boston, Massachusetts
  • +2 more
Jun 27, 2022

Unresectable, Locally Advanced Or Metastatic Renal Cell

Completed
  • Locally Advanced or Metastatic Renal Cell Carcinoma
  • Cabozantinib monotherapy
  • All authorized TKI monotherapies in advanced RCC per FDA label in advanced RCC
  • The Woodlands, Texas
    McKesson Life Sciences
Nov 11, 2021

Advanced Cancer, Clear Cell Renal Cell Carcinoma Trial in Houston (177Lu girentuximab, Nivolumab, Cabozantinib)

Not yet recruiting
  • Advanced Cancer
  • Clear Cell Renal Cell Carcinoma
  • 177Lu girentuximab
  • +3 more
  • Houston, Texas
    MD Anderson Cancer Center
Dec 15, 2022

Advanced Renal Cell Carcinoma Trial (QL1706 Plus Lenvatinib)

Not yet recruiting
  • Advanced Renal Cell Carcinoma
  • QL1706 Plus Lenvatinib
  • (no location specified)
Feb 21, 2022

Advanced Clear Cell Renal Cell Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8 Trial

Recruiting
  • Advanced Clear Cell Renal Cell Carcinoma
  • +3 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Dec 2, 2022

Advanced Kidney Cancer Trial in Tianjin (Pembrolizumab plus Lenvatinib)

Recruiting
  • Advanced Kidney Cancer
  • Pembrolizumab plus Lenvatinib
  • Tianjin, Tianjin, China
    Changyi Quan
Aug 4, 2022

Kidney Cancer Trial in Houston (Axitinib)

Active, not recruiting
Has Results
  • Kidney Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 2, 2022

Advanced Kidney Cancer Trial in Tianjin (Tislelizumab Lenvatinib)

Recruiting
  • Advanced Kidney Cancer
  • Tislelizumab Lenvatinib
  • Tianjin, Tianjin, China
    Changyi Quan
Aug 4, 2022

Advanced Solid Tumors, Solid Tumor, Solid Carcinoma Trial (Belzutifan)

Active, not recruiting
  • Advanced Solid Tumors
  • +15 more
  • (no location specified)
Sep 16, 2022

Advanced Cancer, Advanced Malignancies, Bladder Cancer Trial (AB598, Zimberelimab, Carboplatin)

Not yet recruiting
  • Advanced Cancer
  • +11 more
  • (no location specified)
May 26, 2023

Renal Cell Carcinoma Trial in United States (everolimus and bevacizumab)

Completed
Has Results
  • Renal Cell Carcinoma
  • everolimus and bevacizumab
  • Basking Ridge, New Jersey
  • +6 more
Jan 3, 2022

Renal Cell Carcinoma (RCC) Trial in Heidelberg (Chimeric mAb cG250, Sunitinib malate)

Terminated
Has Results
  • Renal Cell Carcinoma (RCC)
  • Chimeric monoclonal antibody cG250
  • Sunitinib malate
  • Heidelberg, Victoria, Australia
    Austin Health (Ludwig Institute Oncology Unit)
Oct 3, 2022

Locally Advanced or Metastatic Solid Tumors, NSCLC, HNSCC Trial in Australia, United States (RO7502175, Atezolizumab)

Recruiting
  • Locally Advanced or Metastatic Solid Tumors
  • +10 more
  • Aurora, Colorado
  • +6 more
Jan 4, 2023

Advanced Renal Cell Carcinoma Trial in Rochester (Carevive software)

Recruiting
  • Advanced Renal Cell Carcinoma
  • Carevive software
  • Rochester, New York
    University of Rochester - Wilmot Cancer Institute
Jan 4, 2022

(PRO) Registry in Patients With Advanced Renal Cell Carcinoma

Completed
  • Renal Cell Carcinoma
    • Multiple Locations, Germany
      Multiple sites all over Germany
    Mar 24, 2021

    Advanced Melanoma, Renal Cell Carcinoma Trial in New Haven (Nivolumab, Ipilimumab, APX005M)

    Recruiting
    • Advanced Melanoma
    • Renal Cell Carcinoma
    • New Haven, Connecticut
    • +1 more
    Nov 2, 2021

    Advanced Metastatic Clear Cell Renal Cell Carcinoma (CCRCC) Trial in Iowa City (Selenomethionine (SLM), Axitinib)

    Recruiting
    • Advanced Metastatic Clear Cell Renal Cell Carcinoma (CCRCC)
    • Iowa City, Iowa
      University of Iowa Hospitals and Clinics
    Sep 13, 2021

    Advanced Solid Tumor, Advanced/ Metastatic Renal Cell Carcinoma (RCC), Microsatellite Iinstability-high (MSI-H) or Mismatch

    Active, not recruiting
    • Advanced Solid Tumor
    • +3 more
    • TP-1454 monotherapy
    • TP-1454 combination therapy
    • Phoenix, Arizona
    • +8 more
    Nov 18, 2022

    Hepatocellular Carcinoma, Renal Cell Carcinoma Trial in Australia, New Zealand (APL-501, APL-101, Nivolumab)

    Terminated
    • Hepatocellular Carcinoma
    • Renal Cell Carcinoma
    • APL-501
    • +2 more
    • Albury, New South Wales, Australia
    • +8 more
    May 3, 2022

    Metastatic sRCC Trial in Philadelphia (Avelumab, Gemcitabine)

    Recruiting
    • Metastatic sRCC
    • Philadelphia, Pennsylvania
      Abramson Cancer Center of the University of Pennsylvania
    Jul 22, 2021

    Renal Cell Carcinoma, Melanoma, Solid Tumor Trial in Pittsburgh (Phase Ib ARRY-614 + nivolumab, Phase Ib ARRY-614 +

    Recruiting
    • Renal Cell Carcinoma
    • +4 more
    • Phase Ib ARRY-614 + nivolumab
    • +4 more
    • Pittsburgh, Pennsylvania
      UPMC Hillman Cancer Center
    Jan 9, 2022

    Renal Cell Carcinoma Trial in United States (Entinostat, Interleukin-2)

    Active, not recruiting
    • Renal Cell Carcinoma
    • Los Angeles, California
    • +4 more
    Feb 14, 2022